Cargando…

Physiological levels of lipoxin A(4) inhibit ENaC and restore airway surface liquid height in cystic fibrosis bronchial epithelium

In cystic fibrosis (CF), the airway surface liquid (ASL) is depleted. We previously demonstrated that lipoxin A(4) (LXA(4)) can modulate ASL height (ASLh) through actions on Cl(−) transport. Here, we report novel effects of lipoxin on the epithelial Na(+) channel ENaC in this response. ASL dynamics...

Descripción completa

Detalles Bibliográficos
Autores principales: Al‐Alawi, Mazen, Buchanan, Paul, Verriere, Valia, Higgins, Gerard, McCabe, Olive, Costello, Richard W., McNally, Paul, Urbach, Valérie, Harvey, Brian J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246599/
https://www.ncbi.nlm.nih.gov/pubmed/25107986
http://dx.doi.org/10.14814/phy2.12093
_version_ 1782346547892060160
author Al‐Alawi, Mazen
Buchanan, Paul
Verriere, Valia
Higgins, Gerard
McCabe, Olive
Costello, Richard W.
McNally, Paul
Urbach, Valérie
Harvey, Brian J.
author_facet Al‐Alawi, Mazen
Buchanan, Paul
Verriere, Valia
Higgins, Gerard
McCabe, Olive
Costello, Richard W.
McNally, Paul
Urbach, Valérie
Harvey, Brian J.
author_sort Al‐Alawi, Mazen
collection PubMed
description In cystic fibrosis (CF), the airway surface liquid (ASL) is depleted. We previously demonstrated that lipoxin A(4) (LXA(4)) can modulate ASL height (ASLh) through actions on Cl(−) transport. Here, we report novel effects of lipoxin on the epithelial Na(+) channel ENaC in this response. ASL dynamics and ion transport were studied using live‐cell confocal microscopy and short‐circuit current measurements in CF (CuFi‐1) and non‐CF (NuLi‐1) cell cultures. Low physiological concentrations of LXA4 in the picomolar range produced an increase in ASLh which was dependent on inhibition of an amiloride‐sensitive Na(+) current and stimulation of a bumetanide‐sensitive Cl(−) current. These ion transport and ASLh responses to LXA(4) were blocked by Boc‐2 an inhibitor of the specific LXA4 receptor ALX/FPR2. LXA(4) affected the subcellular localization of its receptor and enhanced the localization of ALX/FPR2 at the apical membrane of CF cells. Our results provide evidence for a novel effect of low physiological concentrations of LXA(4) to inhibit airway epithelial Na(+) absorption that results in an ASL height increase in CF airway epithelia.
format Online
Article
Text
id pubmed-4246599
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Wiley Periodicals, Inc.
record_format MEDLINE/PubMed
spelling pubmed-42465992014-12-18 Physiological levels of lipoxin A(4) inhibit ENaC and restore airway surface liquid height in cystic fibrosis bronchial epithelium Al‐Alawi, Mazen Buchanan, Paul Verriere, Valia Higgins, Gerard McCabe, Olive Costello, Richard W. McNally, Paul Urbach, Valérie Harvey, Brian J. Physiol Rep Original Research In cystic fibrosis (CF), the airway surface liquid (ASL) is depleted. We previously demonstrated that lipoxin A(4) (LXA(4)) can modulate ASL height (ASLh) through actions on Cl(−) transport. Here, we report novel effects of lipoxin on the epithelial Na(+) channel ENaC in this response. ASL dynamics and ion transport were studied using live‐cell confocal microscopy and short‐circuit current measurements in CF (CuFi‐1) and non‐CF (NuLi‐1) cell cultures. Low physiological concentrations of LXA4 in the picomolar range produced an increase in ASLh which was dependent on inhibition of an amiloride‐sensitive Na(+) current and stimulation of a bumetanide‐sensitive Cl(−) current. These ion transport and ASLh responses to LXA(4) were blocked by Boc‐2 an inhibitor of the specific LXA4 receptor ALX/FPR2. LXA(4) affected the subcellular localization of its receptor and enhanced the localization of ALX/FPR2 at the apical membrane of CF cells. Our results provide evidence for a novel effect of low physiological concentrations of LXA(4) to inhibit airway epithelial Na(+) absorption that results in an ASL height increase in CF airway epithelia. Wiley Periodicals, Inc. 2014-08-08 /pmc/articles/PMC4246599/ /pubmed/25107986 http://dx.doi.org/10.14814/phy2.12093 Text en © 2014 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of the American Physiological Society and The Physiological Society. http://creativecommons.org/licenses/by/3.0/ This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Al‐Alawi, Mazen
Buchanan, Paul
Verriere, Valia
Higgins, Gerard
McCabe, Olive
Costello, Richard W.
McNally, Paul
Urbach, Valérie
Harvey, Brian J.
Physiological levels of lipoxin A(4) inhibit ENaC and restore airway surface liquid height in cystic fibrosis bronchial epithelium
title Physiological levels of lipoxin A(4) inhibit ENaC and restore airway surface liquid height in cystic fibrosis bronchial epithelium
title_full Physiological levels of lipoxin A(4) inhibit ENaC and restore airway surface liquid height in cystic fibrosis bronchial epithelium
title_fullStr Physiological levels of lipoxin A(4) inhibit ENaC and restore airway surface liquid height in cystic fibrosis bronchial epithelium
title_full_unstemmed Physiological levels of lipoxin A(4) inhibit ENaC and restore airway surface liquid height in cystic fibrosis bronchial epithelium
title_short Physiological levels of lipoxin A(4) inhibit ENaC and restore airway surface liquid height in cystic fibrosis bronchial epithelium
title_sort physiological levels of lipoxin a(4) inhibit enac and restore airway surface liquid height in cystic fibrosis bronchial epithelium
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246599/
https://www.ncbi.nlm.nih.gov/pubmed/25107986
http://dx.doi.org/10.14814/phy2.12093
work_keys_str_mv AT alalawimazen physiologicallevelsoflipoxina4inhibitenacandrestoreairwaysurfaceliquidheightincysticfibrosisbronchialepithelium
AT buchananpaul physiologicallevelsoflipoxina4inhibitenacandrestoreairwaysurfaceliquidheightincysticfibrosisbronchialepithelium
AT verrierevalia physiologicallevelsoflipoxina4inhibitenacandrestoreairwaysurfaceliquidheightincysticfibrosisbronchialepithelium
AT higginsgerard physiologicallevelsoflipoxina4inhibitenacandrestoreairwaysurfaceliquidheightincysticfibrosisbronchialepithelium
AT mccabeolive physiologicallevelsoflipoxina4inhibitenacandrestoreairwaysurfaceliquidheightincysticfibrosisbronchialepithelium
AT costellorichardw physiologicallevelsoflipoxina4inhibitenacandrestoreairwaysurfaceliquidheightincysticfibrosisbronchialepithelium
AT mcnallypaul physiologicallevelsoflipoxina4inhibitenacandrestoreairwaysurfaceliquidheightincysticfibrosisbronchialepithelium
AT urbachvalerie physiologicallevelsoflipoxina4inhibitenacandrestoreairwaysurfaceliquidheightincysticfibrosisbronchialepithelium
AT harveybrianj physiologicallevelsoflipoxina4inhibitenacandrestoreairwaysurfaceliquidheightincysticfibrosisbronchialepithelium